WASHINGTON — A Food and Drug Administration advisory panel recommended on Friday that compounding pharmacies be allowed to ...

Today, a win for RFK Jr., as an FDA panel narrowly voted in favor of allowing compounding pharmacies to produce certain ...

Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He is also the author of the morning Pharmalittle newsletter ...

Federal health officials are investigating a new outbreak of the diarrhea-causing parasite. We don’t know where or which ...

Merck is striking licensing deals for its experimental HIV prevention pill in hope of getting wide-scale production started ...

The Trump administration released its blueprint for U.S. science, calling for shifting hundreds of billions of research ...

The national security framing of the discussion around pharmaceutical supply chain vulnerabilities is a distraction, writes ...

Sarah covers how industries like food and tobacco affect Americans’ bodies and minds. Her interests include ultra-processed foods; smoke-free tobacco; and wellness trends like perimenopause products ...

Every so often, I catch myself wondering, what if I had applied to medical school just two years later? As another class of medical students matriculates, that question has become harder to ignore. On ...

The panel recommended allowing compounding pharmacies to produce popular but unproven BPC-157 and KPV peptides.

Chelsea covers the Department of Health and Human Services with a particular focus on power and influence at the top. Confidential tips can be sent via Signal at chelseacirruzzo.42. WASHINGTON — The ...

Has a wanted fugitive been posing as a biotech executive? And what does it take to develop a therapy for an ultra-rare ...